Capabilities Advancement Demonstrations of Autonomous Mobility Appliqué System Conducted in South Carolina

The U.S. Army Tank-Automotive Research, Development and Engineering Center (TARDEC) and Lockheed Martin successfully completed new tests validating the ability of driverless military-truck convoys to operate successfully and safely in a variety of environments.

A convoy of driverless U.S. Army trucks uses Lockheed Martin AMAS technology to move along a South Carolina roadway at 40 mph.

The second series of demonstrations of the Autonomous Mobility Appliqué System (AMAS) Capabilities Advancement Demonstration (CAD-2) tests were conducted at the Department of Energy’s Savannah River Site in South Carolina.

In the CAD-2 demonstration, AMAS completed a series of fully autonomous convoy tests involving a completely unmanned leader vehicle followed by a convoy of up to six additional follower vehicles (also fully autonomous) operating at speeds as high as 40 mph. The tests doubled the length and speed of convoys previously demonstrated under the program.

Vehicles used in the CAD-2 demonstration included one Family of Medium Tactical Vehicles (FMTV) truck, one Medium Tactical Vehicle Replacement (MTVR) vehicle, two Palletized Load System trucks, two M915 Line-Haul Tractors and one Heavy Equipment Transport.

“I would describe these tests as a successful demonstration of the maturing capabilities of AMAS technology,” said David Simon, AMAS program manager for Lockheed Martin Missiles and Fire Control. “We will conduct further safety testing within the next month, and the program will execute a six-week Operational Demonstration in the July-August timeframe, during which time Soldiers and Marines will assess the system benefits in realistic convoy operations.”

Earlier this year at Fort Hood, Texas, AMAS completed the first CAD series of tests, simulating driverless tactical vehicles navigating hazards and obstacles such as road intersections, oncoming traffic, stalled and passing vehicles, pedestrians and traffic circles in both urban and rural test areas.

The AMAS hardware and software are designed to automate the driving task on current tactical vehicles. The Unmanned Mission Module part of AMAS, which includes a high-performance LIDAR sensor, and additional algorithms, is installed as a kit and can be used on virtually any military vehicle.

Headquartered in Bethesda, Maryland, Lockheed Martin is a global security and aerospace company that employs approximately 113,000 people worldwide and is principally engaged in the research, design, development, manufacture, integration and sustainment of advanced technology systems, products and services. The Corporation’s net sales for 2013 were $45.4 billion.

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Lockheed Martin Corporation. (2019, February 19). Capabilities Advancement Demonstrations of Autonomous Mobility Appliqué System Conducted in South Carolina. AZoRobotics. Retrieved on November 25, 2024 from https://www.azorobotics.com/News.aspx?newsID=5812.

  • MLA

    Lockheed Martin Corporation. "Capabilities Advancement Demonstrations of Autonomous Mobility Appliqué System Conducted in South Carolina". AZoRobotics. 25 November 2024. <https://www.azorobotics.com/News.aspx?newsID=5812>.

  • Chicago

    Lockheed Martin Corporation. "Capabilities Advancement Demonstrations of Autonomous Mobility Appliqué System Conducted in South Carolina". AZoRobotics. https://www.azorobotics.com/News.aspx?newsID=5812. (accessed November 25, 2024).

  • Harvard

    Lockheed Martin Corporation. 2019. Capabilities Advancement Demonstrations of Autonomous Mobility Appliqué System Conducted in South Carolina. AZoRobotics, viewed 25 November 2024, https://www.azorobotics.com/News.aspx?newsID=5812.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.